Stockscreener 앱 받기
52.99
3.61%
1.4425
Exact Sciences Corp 주식(EXAS)의 최신 뉴스
Analysts Have Made A Financial Statement On Exact Sciences Corporation's (NASDAQ:EXAS) First-Quarter Report - Yahoo
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2025 Earnings Call Transcript - Insider Monkey
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus
Exact Sciences Corp Reports Strong Start to 2025 - TipRanks
Exact Sciences (EXAS) Target Price Raised by Barclays to $75 | EXAS Stock News - GuruFocus
Exact Sciences (EXAS) Price Target Raised by RBC Capital | EXAS Stock News - GuruFocus
Exact Sciences: Q1 Earnings Snapshot - GMToday.com
Lobbying Update: $470,000 of EXACT SCIENCES lobbying was just disclosed - Nasdaq
Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect - Barchart.com
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday - Benzinga
EXAS: Evercore ISI Group Raises Price Target for Exact Sciences | EXAS Stock News - GuruFocus
Exact Sciences (EXAS) Sees Target Price Raised by Baird | EXAS S - GuruFocus
Exact Sciences (EXAS) Sees Target Price Raised by Baird | EXAS Stock News - GuruFocus
Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance - Benzinga
Exact Sciences (EXAS) Price Target Raised to $72 by Baird Analys - GuruFocus
RBC Raises Price Target on Exact Sciences to $54 From $52, Keeps Sector Perform Rating - marketscreener.com
Exact Sciences (EXAS) Price Target Raised to $72 by Baird Analyst | EXAS Stock News - GuruFocus
S&P 500 Futures Rise in Premarket Trading; McCormick Vtg, Exact Sciences Lead - Barron's
Exact Sciences to Participate in May Investor Conference | EXAS Stock News - GuruFocus
Exact Sciences to Participate in May Investor Conference - Business Wire
Barclays Elevates Price Target for Exact Sciences (EXAS) to $75 - GuruFocus
Barclays Elevates Price Target for Exact Sciences (EXAS) to $75 | EXAS Stock News - GuruFocus
Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ... - Yahoo Finance
Exact Sciences reports Q1 EPS (54c) vs (60c) last year - TipRanks
Exact Sciences Reports Strong Q1 2025 Results - TipRanks
Exact Sciences Q1 2025 slides: revenue growth accelerates, profitability improves By Investing.com - Investing.com South Africa
Exact Sciences (EXAS) Boosts Revenue Outlook; Shares Rise Post-M - GuruFocus
Exact Sciences Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Exact Sciences Corp (EXAS) Q1 2025 Earnings: Revenue Surpasses E - GuruFocus
Exact Sciences (EXAS) Surpasses Q1 2025 Expectations with 11% Re - GuruFocus
EXACT Sciences earnings missed by $0.21, revenue topped estimates - Investing.com South Africa
Exact Sciences Q1 2025 slides: revenue growth accelerates, profitability improves - Investing.com
Earnings call transcript: Exact Sciences Q1 2025 sees revenue growth, stock surges - Investing.com
Exact Sciences Q1 Adjusted Loss Narrows, Revenue Rises; Shares Up - marketscreener.com
Exact Sciences stock surges 8% on Q1 revenue beat, raised guidance By Investing.com - Investing.com South Africa
Exact Sciences stock surges 8% on Q1 revenue beat, raised guidance - Investing.com India
EXACT SCIENCES CORP SEC 10-Q Report - TradingView
Exact Sciences (EXAS) Q1 Revenue Beats Expectations, Raises Full-Year Outlook | EXAS Stock News - GuruFocus
Exact Sciences Announces First-Quarter 2025 Results | EXAS Stock News - GuruFocus
Earnings Flash (EXAS) Exact Sciences Posts Q1 Revenue $706.8M, vs. FactSet Est of $688.6M - marketscreener.com
Exact Sciences Crushes Q1 Earnings: Revenue Surges 11%, Launches Revolutionary Cancer Detection Tests - Stock Titan
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Exact Sciences reports Q1 results that top analysts’ expectations - Wisconsin State Journal
Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Exact Sciences appoints new board member - Investing.com
Form DEF 14A EXACT SCIENCES CORP For: Jun 12 - StreetInsider
Exact Sciences to Highlight Cologuard® Test Adherence and Predic - GuruFocus
Exact Sciences to Highlight Cologuard Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025 - Business Wire
This Exact Sciences Insider Increased Their Holding In The Last Year - Yahoo Finance
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential - Insider Monkey
2 Reasons to Like EXAS (and 1 Not So Much) - Yahoo Finance
Billionaire George Soros’ 10 Small-Cap Stocks with Huge Upside Potential - Insider Monkey
EXAS Quantitative Stock AnalysisBenjamin Graham - Nasdaq
Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic By Stocktwits - Investing.com India
Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic - MSN
Exact Sciences (EXAS) Launches Oncodetect Test for Enhanced Canc - GuruFocus
Exact Sciences launches the Oncodetect MRD test - TipRanks
Exact Sciences (EXAS) Launches Oncodetect Test for Enhanced Cancer Care | EXAS Stock News - GuruFocus
0.16%
0.03%
자본화:
|
볼륨(24시간):